Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2012
09/12/2012CN102657602A 3,5-dyhydroxyl-4-isopropyl diphenylethene chitosan gel and preparation method thereof
09/12/2012CN102657601A External medicinal formula mainly used for treating ichthyosis and xerodermia and process thereof
09/12/2012CN102657600A Povidone iodine gel for veterinary use and preparation process
09/12/2012CN102657599A Method for preparing bioactive injectable hydrogel materials for oncotherapy
09/12/2012CN102657598A Porous inorganic material based oral preparation of secondary-dispersion insoluble drug and preparation method thereof
09/12/2012CN102657597A Biodegradable super-molecular hydrogel loaded with antitumor medicament and preparation method thereof
09/12/2012CN102219860B FGFR-Fc fusion protein and applications thereof
09/12/2012CN102178650B Alprostadil injection and preparation method thereof
09/12/2012CN102178647B Pranlukast injection preparation
09/12/2012CN102166187B Recombinant human endostatin sustained-release injection oil preparation and preparation process thereof
09/12/2012CN102151245B Castor oil micro-emulsion for Nifeviroc anti-cancer medicine and preparation method thereof
09/12/2012CN102058781B Traditional Chinese medicinal film agent for treating burns and scalds
09/12/2012CN102038700B Bitter-taste-masking erythromycin-cydocarbonate-containing oral composition
09/12/2012CN101961494B Star polymer nano-medicament carrier preparation used for intracellular medicament delivery and preparation method thereof
09/12/2012CN101897960B hNgR-Fc fusion protein vaccine for promoting regeneration and functional recovery of central nerves
09/12/2012CN101891800B Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof
09/12/2012CN101870767B Preparation method of pegylated 1,2-bialiphatic acyl phosphatidylethanolamine
09/12/2012CN101869699B Preparation process of bone peptide soft capsule
09/12/2012CN101829051B 1'-acetoxychavicol acetate injection
09/12/2012CN101646441B Suspension-type eye drop preparation comprising fluorometholone
09/12/2012CN101623398B Colon-specific preparation and preparation method thereof
09/12/2012CN101244039B Novel method for preparing indissoluble medicaments liposome preparations
09/12/2012CN101204445B Soft capsule for hepatitis and preparation method thereof
09/12/2012CN101062957B Gellan gum without organic solvent and production technique thereof
09/12/2012CN101007851B Chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
09/11/2012US8263704 Bioabsorbable surgical composition
09/11/2012US8263664 pH-sensitive polymeric micelles for drug delivery
09/11/2012US8263663 Azide functionalized peptide targeting groups
09/11/2012US8263659 Thyroid receptor ligands
09/11/2012US8263650 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
09/11/2012US8263647 Treatment of sleep disturbances
09/11/2012US8263600 Antifungal composition with enhanced bioavailability
09/11/2012US8263582 Administering two separate dosage forms of a topically active corticosteroid or a pharmaceutically active salt thereof for therapy ofinflammatory bowel disease and sufficient to reduce or eliminate side effects
09/11/2012US8263567 A lipophilic anthracycline with a pharmaceutically acceptable carrier for topical administration to a body surface and which has a higher lipophilicity than doxorubicin; valrubicin applied to mucous membranes; psoriasis; side effect reduction; not doxorubicin, daunorubicin, epirubicin or idarubicin
09/11/2012US8263565 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same
09/11/2012US8263529 Herbicide composition
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263145 Enzyme preparation and process for producing food using the same
09/11/2012US8263128 Solid pharmaceutical dispersions with enhanced bioavailability
09/11/2012US8263127 Photochemical activation of surfaces for attaching biomaterial
09/11/2012US8263121 Solid pharmaceutical preparation
09/11/2012US8263114 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery
09/11/2012US8263112 In vivo use of water absorbent polymers
09/11/2012US8263108 Biodegradable insert; drug delivery
09/11/2012US8263062 Multi-arm polymer prodrugs
09/11/2012CA2637285C Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof
09/11/2012CA2635352C Stabilized antibody formulation
09/11/2012CA2633526C Metal-polysaccharide conjugates: compositions and synthesis
09/11/2012CA2561167C Composition of solifenacin or salt thereof for use in solid formulation
09/11/2012CA2544920C Method for the treatment of multiple sclerosis by inhibiting il-17 activity
09/11/2012CA2526570C Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
09/11/2012CA2478558C Naltrexone hydrochloride compositions
09/11/2012CA2475218C Preparation for oxidation-sensitive compounds and method for making same
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/11/2012CA2467275C Method for preparing gels
09/11/2012CA2466851C Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
09/11/2012CA2462557C Method of stabilizing reduced coenzyme q10
09/07/2012WO2012118376A1 Advanced active liposomal loading of poorly water-soluble substances
09/07/2012WO2012118194A1 Pre-filled syringe filling syringe having resin barrel with aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118193A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118192A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118191A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118190A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118189A1 Hyaluronic acid derivative modified by amino-carbonic acid
09/07/2012WO2012117971A1 Lipid membrane structure, lipid membrane structure production method, and method for encapsulating one of the target substance with a single lipid membrane
09/07/2012WO2012117909A1 Manufacturing method for o/w emulsion composition
09/07/2012WO2012117224A1 Dipyridinium derivatives
09/07/2012WO2012117140A1 Thermosensitive compound for the controlled release of active or indicator substances
09/07/2012WO2012116976A1 Prucalopride oral solution
09/07/2012WO2012116744A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
09/07/2012WO2012116445A1 Chewable vehicle for mouth absorption
09/07/2012WO2012116434A1 Two speed monolithic system for controlled release of drugs
09/07/2012WO2012094360A3 Biotherapeutics for the treatment of infectious diseases
09/07/2012WO2012092421A3 Composition for intravascular delivery of therapeutic composition
09/07/2012WO2012039642A8 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
09/07/2012WO2012010883A3 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile
09/07/2012WO2011101734A3 Taste-masked powder for suspension compositions of methylprednisolone
09/07/2012CA2828636A1 Dipyridinium derivatives
09/07/2012CA2828316A1 Prucalopride oral solution
09/07/2012CA2828050A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
09/07/2012CA2827242A1 Chewable vehicle for mouth absorption
09/07/2012CA2825485A1 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye
09/07/2012CA2822021A1 Vesicle compositions
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120226022 Hydrolytically stable maleimide-terminated polymers
09/06/2012US20120225953 Self-Emulsifying Active Ingredient Formulation and the Use of this Formulation
09/06/2012US20120225952 Non-aqueous silicone-based ophthalmic formulations
09/06/2012US20120225932 Process for the production of polyamines
09/06/2012US20120225832 Amphiphilic Compositions and Methods for Preparing and Using Same
09/06/2012US20120225826 Transporters Comprising Spaced Arginine Moieties
09/06/2012US20120225825 Cyclodextrin-based polymers for therapeutic delivery
09/06/2012US20120225810 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
09/06/2012US20120225162 Method and system for weight management
09/06/2012US20120225127 Clay nanocomposite forming microcapsule useful for guest encapsulation and process thereof
09/06/2012US20120225116 Biodegradable polyphosphazenes containing pyrrolidone side groups
09/06/2012US20120225102 Perfluorocarbon gel formulations
09/06/2012US20120225101 Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry
09/06/2012US20120225100 Articlea and processes for Making a Porous Disintegratable Solid Substrate for Personal Health Care Applications
09/06/2012US20120225095 Production of carboxylic acid and salt co-products
09/06/2012US20120225041 Methods and compositions for treating tissue using silk proteins
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 1712